Century Therapeutics (NASDAQ: IPSC) is harnessing the power of adult stem cells to develop curative cell therapy products for cancer that we believe will allow us to overcome the limitations of first-generation cell therapies. Our genetically engineered, iPSC-derived iNK and iT cell product candidates are designed to specifically target hematologic and solid tumor cancers. We are leveraging our expertise in cellular reprogramming, genetic engineering, and manufacturing to develop therapies with the potential to overcome many of the challenges inherent to cell therapy and provide a significant advantage over existing cell therapy technologies. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provide an unparalleled opportunity to advance the course of cancer care. For more information on Century Therapeutics please visit www.centurytx.com.

Muhlenberg College aims to develop independent critical thinkers who are intellectually agile, characterized by a zest for reasoned and civil debate, committed to understanding the diversity of the human experience, able to express ideas with clarity and grace, committed to lifelong learning, equipped with ethical and civic values and prepared for lives of leadership and service.The College is committed to providing an intellectually rigorous education within the context of an inclusive and diverse campus; we strongly believe that diversity is essential to learning and to our success as a pluralistic community. Our curriculum integrates the traditional liberal arts with selected preprofessional studies. Our faculty are passionate about teaching, value close relationships with students and are committed to the pedagogical and intellectual importance of research.All members of our community are committed to educating the whole person through experiences within and beyond the classroom. Honoring its historical heritage from the Lutheran Church and its continuing connection with the Evangelical Lutheran Church in America, Muhlenberg encourages, welcomes and celebrates a variety of faith traditions and spiritual perspectives.

The Commercial Club of Chicago works to shape Chicago’s future to make our region a better place for everyone to live, work, and do business.

The Economic Club of Chicago fosters meaningful connections among Chicago leaders to encourage dialogue on important economic and social issues and to cultivate the next generation of civic leadership.

The Executives’ Club of Chicago is the premier resource for connecting, developing, and growing best-in-class leaders to strengthen themselves and their organizations. It provides established and emerging leaders opportunities to develop and nurture meaningful relationships, participate in innovative programming, and gain world-class knowledge to expand their perspectives and sharpen their capabilities.Through cutting edge thought leadership, leadership development and mentoring initiatives, and member experiences, the Exec Club brings together business, civic and academic leaders from all industries to discuss issues and opportunities affecting business in Chicago and the world.

The Civic Committee of the Commercial Club of Chicago works with business leaders, public officials, and other civic organizations on game-changing initiatives to promote the social and economic well-being of the Chicagoland Region

At Horizon, we believe science and compassion must work together to transform lives. Our mission to deliver medicines for rare, autoimmune and severe inflammatory diseases and provide compassionate support comes from our strong and simple philosophy to make a meaningful difference for patients and communities in need.

We are a group of committed volunteers, experienced coaches, well versed athletes and active community members who have joined forces to create a well-balanced, safe and competitive football league for young athletes. Athletes range from 3rd to 9th grade with different skill levels and experience, but all have the desire to compete against some of the best travel football teams in the region.

BIO is the world’s largest advocacy association representing member companies, state biotechnology groups, academic and research institutions, and related organizations across the United States and in 30+ countries.

iBIO is a life sciences industry association that represents the 85,000 life sciences employees at member companies, universities, service providers and venture firms. iBIO promotes the industry’s value to the public and policymakers; connects innovators to investment and talent; stimulates collaboration and fosters the next generation of innovators and entrepreneurs to transform patient lives through groundbreaking research and works to grow the Illinois economy.

Changing the course of autoimmune disease. Aurinia exists to make a difference. Our mission is to transform people’s lives by delivering therapeutics that change the course of autoimmune disease. From the earliest days of the company, we’ve applied a creative, thoughtful and responsible approach to developing therapies for people in need.In addition to driving adoption of our approved therapy for appropriate people with lupus nephritis, we are also actively pursuing a broader portfolio of innovative drugs for autoimmune disease.Our strategy leverages the skills and knowledge of our incredible team and our deep experience in principled drug development and commercialization. Together, we are driven to make an impact for our patient communities as advocates and partners in innovation.

Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary spherical nucleic acid (SNA™) architecture is designed to unlock the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address inflammatory diseases, genetic disorders and oncology. Exicure is based in Chicago, IL.

Incubated by the City of Chicago and initially funded by the State of Illinois and area businesses, MATTER opened in February 2015 with 30 startup companies and a few programs, and has since grown to include hundreds of startup and growth stage companies from around the world, dozens of corporate partners and a diverse array of programs supporting healthcare entrepreneurship and innovation.Today, our startups range from those that are barely more than ideas, to companies with millions of dollars in revenue and dozens of employees. Our partners represent every sector of healthcare.We believe collaboration between entrepreneurs and industry leaders is the fastest, most effective way to accelerate innovation, advance care and improve lives.With MATTER’s non-profit and no-equity model as the foundation, our community is a neutral platform where healthcare entrepreneurs can come together with industry leaders, scientists and clinicians from across the globe to collaborate on developing next-generation healthcare and life sciences technologies.

Chaired by Mayor Lori Lightfoot, World Business Chicago drives regional economic growth. WBC collaborates to create jobs, cultivate talent and put Chicago at the forefront of the global economy.

PhRMA represents the country’s leading biopharmaceutical research companies and supports the search for new treatments and cures.

XOMA combines a portfolio of innovative therapeutic antibodies, both in late-stage clinical development and in preclinical research, with its recently launched commercial operations. XOMA focuses its antibody research and development on allosteric modulation, which offers opportunities for new classes of therapeutic antibodies to treat a wide range of human diseases. XOMA's world-class monoclonal antibody technologies have contributed to the development of marketed biologics with a total of more than $1 billion in annual sales and for which XOMA received substantial royalties. The company also has a strong track record of product discovery and development collaborations with pharmaceutical and biotechnology companies and the U.S. government and has licensed certain of its fundamental technologies to more than 60 companies.In 2010, XOMA partnered with Les Laboratoires Servier (Servier), France's leading independent pharmaceutical company, for the development of XOMA’s lead product gevokizumab (IL-1 beta modulating antibody). This collaboration brings together Servier's resources and expertise in pharmaceutical product development and commercialization with XOMA's expertise in biologics clinical development and manufacturing capabilities.Today, XOMA’s principal activities are centered on the advancement of gevokizumab and the advancement of its preclinical compounds. XOMA is located in Berkeley, California.

Raptor Pharmaceuticals (NASDAQ: RPTP) was a commercial-stage, global biopharmaceutical company committed to developing and commercializing life-altering therapeutics for orphan diseases. The focus was to help patients with rare, debilitating and potentially fatal diseases by leveraging our deep understanding of cellular metabolic pathways to develop medicines that address serious unmet medical needs. Raptor was purchased by Horizon Therapeutics plc in October 2016.

IDM was focused on the development of innovative cancer products that either destroy cancer cells by activating the immune system or prevent tumor recurrence by triggering a specific adaptive immune response. IDM was sold to Takeda in June 2009

Built and led the global development, manufacturing, commercial launch and life cycle management strategy for the multi-billion dollar biologic HUMIRA.

Wyeth is now part of Pfizer